AstraZeneca resumes coronavirus vaccine trial

  • British clinical trials for the AstraZeneca coronavirus vaccine have resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so. Clinical trials were suspended this week due to an illness in a study subject in Britain.

  • The United Arab Emirates reported 1,007 new cases of the coronavirus, its highest daily number since the pandemic broke out. The country conducted more t

    Saturday, September 12

    16:41 GMT – French PM to end self-isolation after another negative COVID-19 test

    French Prime Minister Jean Castex has tested negative for COVID-19 again and will come out of self-isolation, a week after being in contact with someone who had a positive result, his office said.

    Castex had already tested negative for COVID-19 since sharing a car last weekend with the director of the Tour de France cycle race, who later tested positive.

    On Friday the prime minister outlined plans to speed up testing and toughen measures in certain cities as the government seeks to avoid a repeat of the spring’s nationwide lockdown.

    16:08 GMT – UK records 3,497 more confirmed cases of COVID-19

    The United Kingdom reported 3,497 confirmed new cases of COVID-19, according to government data published, compared with 3,539 a day earlier.

    It also reported a further nine new deaths from the coronavirus.

    Friday’s figure was the largest number of daily cases to be reported since mid-May, and Britain is to bring in a new ban on social gatherings on Monday in a bid to curb the increasing rise in infections.

    15:32 GMT – Myanmar residents barricade city streets as coronavirus cases rise

    Some residents of Myanmar’s biggest city used pieces of wood and corrugated iron to make barricades around their neighbourhoods, trying to keep out COVID-19 as the country grapples with a second wave of infections.

    The Southeast Asian nation has reported a total of 2,625 coronavirus cases and 15 deaths. The number of infections has quadrupled since mid-August, when the virus resurfaced in the western state of Rakhine after weeks without a domestic case.

    Last week, government authorities issued stay-at-home orders for residents, and airlines and buses suspended services in and out of the city.

    Aung Zaw Min, the chief of a district in Kyimyidaing township who was guarding one of the barriers, said residents had been careless about keeping the virus at bay after the previously low rate of infections.

    15:09 GMT – Pfizer, BioNTech propose expanding COVID-19 vaccine trial

    Pfizer Inc and BioNTech SE have proposed to the US Food and Drug Administration (FDA) to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to about 44,000 participants, the companies said.

    The initial target figure for the trial was up to 30,000 participants.

    14:17 GMT – AstraZeneca resumes COVID-19 vaccine trial after UK green light

    British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so, the company said.

    The late-stage trials of the experimental vaccine, one of the most advanced in development, were suspended this week after an illness in a study subject in Britain.

    “The standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators,” AstraZeneca said.

    “The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume.”

    han 95,000 tests and registered one death and 521 recoveries.

  • More than 28.5 million people around the world have been diagnosed with the coronavirus and more than 916,000 have died, according to Johns Hopkins University. About 19.2 million patients have recovered.

Related Articles

Back to top button